Trade EOLS anytime, even after market hours
Regulated by
MAS
Trusted by
400,000+ users
Evolus, Inc. (EOLS) is trading at US$9.02, down 0.36% today as of Sep 4, 10:42 EDT. The company has a market capitalisation of US$554.16M. Over the past 52 weeks, EOLS has traded between US$3.86 and US$9.15. On Syfe you can trade EOLS with $0 commission and add it to your watchlist.
| Previous close | US$9.05 |
|---|---|
| Market cap | US$554.16M |
| P/E ratio | 58.61 |
| 52-week range | US$3.86 – US$9.15 |
| Volume | 733.28K |
| Exchange | US |
Add to Watchlist
Set Price Alert
Evolus, Inc.
Evolus, Inc. is a medical aesthetics company, which engages in the provision of medical aesthetic treatments and procedures. It offers products under the brand of Jeuveau. The company was founded by Scott Cannizzaro in November 2012 and is headquartered in Newport Beach, CA.
Year: 2018
Evolus Partners With IBSA to Develop, Commercialize Profhilo in US
Jul 8, 1:50 PM · MT Newswires
Evolus Plans to Launch Estyme Collection in Europe
May 11, 2:25 PM · MT Newswires
Evolus, Inc. (EOLS) stock is trading at US$9.02, -0.36% from the previous close of US$9.05.
The market cap for Evolus, Inc. (EOLS) stock is approximately US$554.16M.
The price-to-earnings ratio for Evolus, Inc. (EOLS) is 58.61, based on the latest reported earnings.
The 52-week high for Evolus, Inc. (EOLS) stock is US$9.15.
The 52-week low for Evolus, Inc. (EOLS) stock is US$3.86.
Evolus, Inc. (EOLS) does not currently pay a dividend.
Stay on top of EOLS
Price moves, news and earnings — straight to your inbox.
Est. order value
US$0.00
Snapshot
